Kathy Zhou: I think, right at this moment, they do have a very strong safety profile
VESPER-2 VESPER-2 was a randomized, multicenter, double-blind, 28-week placebo-controlled trial that investigated the efficacy and safety of weekly berobenatide doses in adults with obesity or overweight and type 2 diabetes
Patients on similar GLP-1 receptor agonists, Orlistat, or those dealing with gallstones and uncontrollable appetite should also seek alternative treatments
These are some of the top treatments theyre chasing in the war against the dreaded Ozempic face. Beating the bulge but surrendering to sag Drugs like Ozempic and Wegovy work by mimicking a naturally occurring hormone in the body that tells your brain youre full crushing cravings and helping many users drop pounds in record time
Simultaneously, Ozempic has had success as a diabetes management tool, but is coming up in conversations about its antiaging properties and weight control powers as well